Valuation: China Biotech Services Holdings Limited

Market Cap 634M 80.89M 71.14M 66.09M 60.78M 114M 7.83B 116M 790M 308M 3.82B 304M 297M 13.26B P/E 2024
-2.49x
P/E 2025 -11.2x
Enterprise Value 1.02B 130M 114M 106M 97.47M 183M 12.56B 186M 1.27B 494M 6.13B 487M 476M 21.26B EV / Sales 2024
9.45x
EV / Sales 2025 15.7x
Free-Float
35.46%
Yield 2024 *
-
Yield 2025 -
1 day-1.54%
1 week-1.54%
Current month+47.13%
1 month+20.75%
3 months-4.48%
6 months-15.79%
Current year-18.99%
1 week 0.58
Extreme 0.58
0.7
1 month 0.42
Extreme 0.425
0.73
Current year 0.3
Extreme 0.3
0.92
1 year 0.3
Extreme 0.3
1.33
3 years 0.25
Extreme 0.25
1.33
5 years 0.25
Extreme 0.25
2.64
10 years 0.16
Extreme 0.156
2.64
Manager TitleAgeSince
Director of Finance/CFO - -
Compliance Officer 55 26/05/2022
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 60 07/08/2017
Director/Board Member 44 15/09/2017
Chairman 55 28/08/2017
Date Insider Type Main position Quantity % Market Cap.
30/3/26 Other

Chairman

3,600,000 0.3690%
2/9/24 Other

Director

3,220,000 0.3300%
13/6/24 Other

Director

5,000,000 0.5191%
Change 5-day change 1-year change 3-year change Capi.($)
-1.54%-1.54%-14.67%-17.95% 80.89M
-1.10%+0.37%+72.82%+42.43% 136B
+1.25%-2.40%+6.58%+32.04% 83.52B
+1.27%+3.79%+2.63%+54.68% 27.44B
+8.61%+8.83%+33.68%+57.86% 25.23B
+1.32%0.00%-14.98%-28.49% 20.05B
+1.88%-0.09%+25.72%+159.24% 17.14B
-2.38%-6.13%+1.72%-2.46% 14.55B
+0.94%+0.11%+54.82%+127.93% 15.04B
-0.42%+0.90%-6.92%-12.29% 12.98B
Average +1.36%-0.31%+16.14%+41.30% 35.24B
Weighted average by Cap. +1.98%+0.22%+34.91%+43.44%

Financials

2024 2025
Net sales 70.51M 8.99M 7.91M 7.35M 6.76M 12.67M 871M 12.9M 87.86M 34.27M 425M 33.76M 33.03M 1.47B 73.5M 9.37M 8.24M 7.66M 7.04M 13.21M 908M 13.45M 91.59M 35.72M 443M 35.19M 34.43M 1.54B
Net income -198M -25.27M -22.23M -20.65M -18.99M -35.61M -2.45B -36.25M -247M -96.31M -1.19B -94.87M -92.82M -4.14B -68.78M -8.77M -7.71M -7.17M -6.59M -12.36M -849M -12.58M -85.7M -33.43M -414M -32.93M -32.22M -1.44B
Net Debt 169M 21.54M 18.95M 17.6M 16.19M 30.36M 2.09B 30.9M 210M 82.1M 1.02B 80.88M 79.13M 3.53B 383M 48.82M 42.94M 39.89M 36.69M 68.8M 4.73B 70.04M 477M 186M 2.31B 183M 179M 8B
Logo China Biotech Services Holdings Limited
China Biotech Services Holdings Ltd, formerly Rui Kang Pharmaceutical Group Investments Ltd, is an investment holding company principally engaged in the provision of medical health check services. The Company operates its business through six segments. The Medical and Health Related Services segment provides medical laboratory testing services and health check services. The Insurance Brokerage segment is engaged in the provision of brokerage services. The Immunotherapy segment provides tumor immune call therapy, immune cell storage and health management services. The Pharmaceutical Products segment is engaged in the manufacture, research and development, sale and distribution of health related and pharmaceutical products. The Securities segment is engaged in the trading of securities. The Others segment is engaged in the money lending business and provision of logistic services.
Employees
142
Date Price Change Volume
24/07/26 HKD 0.6400 -1.54% 505,000
23/07/26 HKD 0.6500 0.00% 180,000
22/07/26 HKD 0.6500 -1.52% 220,000
21/07/26 HKD 0.6600 +1.54% 575,000
20/07/26 HKD 0.6500 0.00% 175,000
  1. Stock Market
  2. Stocks
  3. 8037 Stock